Positive CHMP Opinion for Fruquintinib | 26-Apr-2024 | 13:30 | RNS |
Vesting of Awards Under the LTIP | 22-Apr-2024 | 09:30 | RNS |
2023 Annual Report and Notice of AGM | 08-Apr-2024 | 09:30 | RNS |
LTIP and Share Option Scheme | 14-Mar-2024 | 09:00 | RNS |
Vesting of awards under the LTIP | 05-Mar-2024 | 08:30 | RNS |
2023 Full Year Results and Business Updates | 28-Feb-2024 | 11:30 | RNS |
HUTCHMED to Announce 2023 Final Results | 01-Feb-2024 | 08:30 | RNS |
Blocklisting Six Monthly Return | 29-Dec-2023 | 08:30 | RNS |
Total Voting Rights | 29-Dec-2023 | 08:30 | RNS |
Overseas Regulatory Announcement | 21-Dec-2023 | 10:00 | RNS |
Overseas Regulatory Announcement | 07-Dec-2023 | 10:04 | RNS |
Total Voting Rights | 30-Nov-2023 | 08:30 | RNS |
U.S. FDA Approval of FRUZAQLAâ„¢... | 09-Nov-2023 | 07:00 | RNS |
Vesting of awards under the LTIP | 24-Oct-2023 | 09:30 | RNS |
Total Voting Rights | 29-Sep-2023 | 09:30 | RNS |
Currency | UK Pounds |
Share Price | 310.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 326.00 |
52 Week Low | 173.60 |
Volume | 0 |
Shares Issued | 871.26m |
Market Cap | £2,700.89m |
Beta | 0.02 |
RiskGrade | 226 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
You are here: research